Does the Supreme Court ruling mean the EPA will start regulating car emissions?

A summary of what's in the major U.S. newspapers.
April 3 2007 6:31 AM

Sin of Emission

Everyone leads (and the Wall Street Journal tops its world wide newsbox) with the U.S. Supreme Court's 5-4 ruling that the Environmental Protection Agency may regulate automobile emissions contributing to global warming. The ruling does not force the agency to regulate, but it leaves the agency open to further legal action under the Clean Air Act if it fails to do so.

The Washington Post calls the decision a "rebuke" of the Bush administration's stance on global warming. The decision saw moderate conservative Justice Anthony M. Kennedy side with the more liberal wing of court. The New York Times delves into the issue of "standing" in the case. The dissenting opinion focused not on the facts of the case, but that the defendants should never have been able to bring the matter before the court at all. The majority opinion ruled that one of the defendants, the state of Massachusetts, met all the tests for standing, which were soften out of deference for its statehood. That extra consideration for states was key to getting Anthony's vote for the opinion, the paper reports. USA Today notes that the decision is a blow to the Alliance of Automobile Manufacturers, who will now likely turn to Congress for new laws to avoid having to build lower emissions vehicles. The Los Angeles Timesis the least ebullient, citing several hurdles California will have to clear to enforce its own tougher emissions limits. The WSJ looks at the economic impact of the decision.

Advertisement

The WP off-leads, the NYT fronts and the other papers tease analysis of Republican presidential candidates preliminary fundraising disclosures. Former Mass. Gov. Mitt Romney brought in $21 million, $6.5 million of which reportedly was brought in by a single day's fundraising. In the same breath, the papers all mention Sen. John McCain's disappointing $12.5 million third-place showing. The NYT focuses on Romney's support from Wall Street and from fellow Mormons. The WP chalks McCain's performance up to sluggish organization and lingering damage from the 2000 race.  All the papers are careful, to varying degrees, to insist that money really isn't everything in politics.

The LAT off-leads with a scoop from Iraq, reporting that militants formerly loyal to cleric Muqtada Sadr are being siphoned off by other militant groups, some of which may have Iranian backing. Sadr is losing support because he urged his followers to freeze their activities at U.S. behest. Officials worry that if Sadr loses control of his people, it will be much harder to influence Shiite militants.

In absence of any sort of hard data from the Obama campaign, the NYT off-leads with a soft feature on how the Obama raises money, drawing examples primarily from his 2004 Senate race. Readers looking for insight into Obama's current operation can likely skip it.

USAT  and the LAT  tease the Florida Gator's victory in the NCAA basketball tournament for the second year in a row.


The WP fronts the subprime mortgage lender industry's collapse claiming its largest victim, New Century Financial, which issued $51.6 billion in subprime loans last year.

The LAT fronts word that Sam Zell, a Chicago real estate mogul, bought Tribune Co., publishers of the LAT, the Chicago Tribune and the Baltimore Sun, among other paper, along with several TV stations and the Chicago Cubs. Zell will take the company private, buying out stockholders at $34 a share. The paper estimates that Zell stands to make a lot of money on the deal. But before you accuse the LAT of bias, consider: the NYT points out under the fold that Zell bought an $8.2 billion company for just $315 million of his own money. The NYT also says that music executive David Geffen remains interested in the LAT, though Zell has said he does not want to break up the company, apart from selling off the Cubs at the end of the season.

Pharmaceutical giant Pfizer stands to loose billions because of health plans pushing the generic version of Pfizer's blockbuster anti-cholesterol drug Lipitor. Now Pfizer is trying to convince doctors to help justify the more expensive drug to insurers, reportsUSAT.

The WP traces the origin of the document the Bush administration used in pre-war claims that Iraq was trying to buy Uranium from Nigeria.

TODAY IN SLATE

Justice Ginsburg’s Crucial Dissent in the Texas Voter ID Case

The Jarring Experience of Watching White Americans Speak Frankly About Race

How Facebook’s New Feature Could Come in Handy During a Disaster

The Most Ingenious Teaching Device Ever Invented

Sprawl, Decadence, and Environmental Ruin in Nevada

View From Chicago

You Should Be Able to Sell Your Kidney

Or at least trade it for something.

Space: The Next Generation

An All-Female Mission to Mars

As a NASA guinea pig, I verified that women would be cheaper to launch than men.

Terrorism, Immigration, and Ebola Are Combining Into a Supercluster of Anxiety

The Legal Loophole That Allows Microsoft to Seize Assets and Shut Down Companies

  News & Politics
Jurisprudence
Oct. 19 2014 1:05 PM Dawn Patrol Justice Ruth Bader Ginsburg’s critically important 5 a.m. wake-up call on voting rights.
  Business
Business Insider
Oct. 19 2014 11:40 AM Pot-Infused Halloween Candy Is a Worry in Colorado
  Life
Outward
Oct. 17 2014 5:26 PM Judge Begrudgingly Strikes Down Wyoming’s Gay Marriage Ban
  Double X
The XX Factor
Oct. 17 2014 4:23 PM A Former FBI Agent On Why It’s So Hard to Prosecute Gamergate Trolls
  Slate Plus
Tv Club
Oct. 20 2014 7:15 AM The Slate Doctor Who Podcast: Episode 9 A spoiler-filled discussion of "Flatline."
  Arts
Brow Beat
Oct. 20 2014 8:32 AM Marvel’s Civil War Is a Far-Right Paranoid Fantasy—and a Mess. Can the Movies Fix It?
  Technology
Future Tense
Oct. 17 2014 6:05 PM There Is No Better Use For Drones Than Star Wars Reenactments
  Health & Science
Bad Astronomy
Oct. 20 2014 7:00 AM Gallery: The Red Planet and the Comet
  Sports
Sports Nut
Oct. 16 2014 2:03 PM Oh What a Relief It Is How the rise of the bullpen has changed baseball.